» Articles » PMID: 7534679

Nonsurgical Management of Primary Cholangiocarcinoma. Retrospective Analysis of 40 Cases

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1995 Mar 1
PMID 7534679
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Forty patients with cholangiocarcinoma (23 men, 17 women) underwent nonsurgical palliative biliary drainage over a period of 12 years. All were surgically unfit or had unresectable disease. All were jaundiced at presentation with a mean serum bilirubin of 11.5 +/- 1.9 mg/dl. Thirty patients (75%) had hilar obstruction. Twenty-eight were drained percutaneously, three endoscopically and nine by a combined endoscopic and percutaneous procedure. Technical success was 97.5%. Final mean bilirubin was 1.5 +/- 0.4 mg/dl. Minor complications occurred in 10 (25%) patients, and major complications in four (10%). Procedure-related mortality was 2.5% with a 30-day mortality of 7.5%. Mean survival was 8.2 +/- 0.5 months. Stent changes were required in eight patients. In patients with inoperable or unresectable cholangiocarcinoma, percutaneous or endoscopic biliary drainage offers effective palliation.

Citing Articles

Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma.

Bhudhisawasdi V, Muisuk K, Areejitranusorn P, Kularbkaew C, Khampitak T, Saeseow O J Cancer Res Clin Oncol. 2003; 130(2):87-92.

PMID: 14648209 DOI: 10.1007/s00432-003-0515-x.


Diagnosis, Staging, and Treatment of Cholangiocarcinoma.

Yoon J, Gores G Curr Treat Options Gastroenterol. 2003; 6(2):105-112.

PMID: 12628069 DOI: 10.1007/s11938-003-0011-z.


Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, Kockerling F Dig Dis Sci. 2000; 45(2):317-24.

PMID: 10711445 DOI: 10.1023/a:1005412626515.


Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.

Zidi S, Prat F, Le Guen O, RONDEAU Y, Pelletier G Gut. 1999; 46(1):103-6.

PMID: 10601064 PMC: 1727781. DOI: 10.1136/gut.46.1.103.


Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction.

Nomura T, Shirai Y, Hatakeyama K Dig Dis Sci. 1999; 44(3):542-6.

PMID: 10080147 DOI: 10.1023/a:1026653306735.


References
1.
Yamakawa T, Esguerra Jr R, Kaneko H, Fukuma E . Percutaneous transhepatic endoprosthesis in malignant obstruction of the bile duct. World J Surg. 1988; 12(1):78-84. DOI: 10.1007/BF01658490. View

2.
Reding R, Buard J, Lebeau G, Launois B . Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg. 1991; 213(3):236-41. PMC: 1358334. DOI: 10.1097/00000658-199103000-00010. View

3.
Miyazaki K, Nagafuchi K, Nakayama F . Bypass procedure for bile duct cancer. World J Surg. 1988; 12(1):64-7. DOI: 10.1007/BF01658488. View

4.
Sako K, SEITZINGER G, Garside E . Carcinoma of the extrahepatic bile ducts; review of the literature and report of six cases. Surgery. 1957; 41(3):416-37. View

5.
FALKSON G, MacIntyre J, MOERTEL C . Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer. 1984; 54(6):965-9. DOI: 10.1002/1097-0142(19840915)54:6<965::aid-cncr2820540603>3.0.co;2-x. View